Ads
    Related paper
  1. Lung Cancer of Unknown Primary Site with EGFR Mutation as Indicated by Frozen Bone Specimen
  2. EGFR and KRAS Oncogene Expressions Among Lung Cancer Patients in North Sumatera
  3. Extracellular Domain Mutation of ErbB2 Status in Japanese Lung Cancer Patients
  4. Comparison of EGFR with Other Molecular, Demographic and Clinicopathologic Data in Nonsmall Cell Lung Carcinoma: A Study from Tertiary Cancer Centre from Western Part of India
  5. The diagnostic value of the p16ink marker for verification of tumors of unknown primary site in women with isolated lesion of inguinal lymph nodes
  6. Brigatinib treatment for primary lung lesions in non-small-cell lung cancer based on ALK gene rearrangement detected in resected brain metastases: A case report and literature review
  7. Nanopharmaceutical Approach for Enhanced Anti-cancer Activity of Betulinic Acid in Lung-cancer Treatment via Activation of PARP: Interaction with DNA as a Target -Anti-cancer Potential of Nano-betulinic Acid in Lung Cancer-
  8. The Future of Telerehabilitation in Lung Cancer: An Observational Study Investigating Access to Technology in the Lung Cancer Population
  9. Post-cancer Treatment with Condurango 30C Shows Amelioration of Benzo[a]pyrene-induced Lung Cancer in Rats Through the Molecular Pathway of Caspase-3-mediated Apoptosis Induction -Anti-lung cancer potential of Condurango 30C in rats-
  10. Evaluation of Overall Survival Rate of Patients with Metastatic Colorectal Cancer Depending on Choice of Treatment, Location of Primary Focus and RAS Genes Mutation Status